No abstract

No abstract

RESULTS. Combined (86%) were alive: 15 (71.4%) had tumor free bladder, of whom 3 had superficial recurrence successfully treated with endovesical therapy and 1 had distant metastases. Three patients were submitted to cystectomy, one for superficial recurrence and hematuria and two for invasive bladder recurrence. Presented in part at the American Society for CONCLUSIONS. This study defines the MTDs of CDDP and 5-FU concomitantly Therapeutic Radiology and Oncology meeting, administered with hyperfractionated radiotherapy. The low toxicity observed and